Articles with "death" as a keyword



A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer

Sign Up to like & get
recommendations!
Published in 2017 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2016.3841

Abstract: Importance There is increasing interest in the effect of cardiovascular disease on cancer survivors. However, there are limited contemporary population-based data on the risk of cardiovascular death after early-stage breast cancer. Objective To describe the… read more here.

Keywords: death; breast cancer; early stage; cancer ... See more keywords

Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction

Sign Up to like & get
recommendations!
Published in 2018 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2018.1049

Abstract: Importance The majority of sudden and/or arrhythmic deaths (SAD) in patients with coronary heart disease occur in those without severe systolic dysfunction, for whom strategies for sudden death prevention are lacking. Objective To provide contemporary… read more here.

Keywords: patients coronary; death; heart; heart disease ... See more keywords

Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis

Sign Up to like & get
recommendations!
Published in 2018 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2018.2093

Abstract: Importance Cardiac amyloidosis is an underdiagnosed disease and is highly fatal when untreated. Early diagnosis and treatment with the emerging novel therapies significantly improve survival. A comprehensive analysis of amyloidosis-related mortality is critical to appreciate… read more here.

Keywords: death; 1979 2015; mortality; amyloidosis ... See more keywords

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.

Sign Up to like & get
recommendations!
Published in 2020 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2020.4511

Abstract: Importance Sodium-glucose cotransporter 2 (SGLT2) inhibitors favorably affect cardiovascular (CV) and kidney outcomes; however, the consistency of outcomes across the class remains uncertain. Objective To perform meta-analyses that assess the CV and kidney outcomes of… read more here.

Keywords: sglt2 inhibitors; death; patients type; type diabetes ... See more keywords
Photo from wikipedia

Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.

Sign Up to like & get
recommendations!
Published in 2021 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2021.0660

Abstract: Importance Sodium-glucose cotransporter 2 inhibitors, such as dapagliflozin, promote renal glucose excretion and reduce cardiovascular (CV) deaths and hospitalizations for heart failure (HHF) among patients with type 2 diabetes. The relative CV efficacy and safety… read more here.

Keywords: patients type; death; hhf; type diabetes ... See more keywords
Photo from wikipedia

Genetic Variants Associated With Unexplained Sudden Cardiac Death in Adult White and African American Individuals.

Sign Up to like & get
recommendations!
Published in 2021 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2021.1573

Abstract: Importance Unexplained sudden cardiac death (SCD) describes SCD with no cause identified. Genetic testing helps to diagnose inherited cardiac diseases in unexplained SCD; however, the associations between pathogenic or likely pathogenic (P/LP) variants of inherited… read more here.

Keywords: unexplained sudden; death; genetic variants; sudden cardiac ... See more keywords

Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction

Sign Up to like & get
recommendations!
Published in 2024 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2023.5318

Abstract: Key Points Question What is the mode of death and the association of dapagliflozin with cause-specific death in patients with heart failure with improved ejection fraction (HFimpEF)? Findings In this post hoc analysis of the… read more here.

Keywords: failure improved; dapagliflozin; mode death; improved ejection ... See more keywords

Survival After Initial Stress Testing vs Anatomic Testing in Suspected Coronary Artery Disease: Long-Term Follow-Up of the PROMISE Randomized Clinical Trial.

Sign Up to like & get
recommendations!
Published in 2025 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2025.2882

Abstract: Importance Symptoms suggestive of coronary artery disease (CAD) often require noninvasive testing for diagnostic and prognostic evaluation. Objective To determine long-term outcomes in patients randomized to functional (stress) vs anatomic (coronary computed tomographic angiography [CTA])… read more here.

Keywords: value interaction; trial; stress; death ... See more keywords

Decreasing Blood Pressure in Older Patients.

Sign Up to like & get
recommendations!
Published in 2018 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2017.7035

Abstract: One of my patients, a woman in her late 80s, has required 4 drugs at high doses for many years to keep her systolic blood pressure under 160 mm Hg. Over a 3-month period earlier… read more here.

Keywords: death; age; year; blood pressure ... See more keywords
Photo by jeremybishop from unsplash

Mortality Among Unsheltered Homeless Adults in Boston, Massachusetts, 2000-2009

Sign Up to like & get
recommendations!
Published in 2018 at "JAMA Internal Medicine"

DOI: 10.1001/jamainternmed.2018.2924

Abstract: Importance Previous studies have shown high mortality rates among homeless people in general, but little is known about the patterns of mortality among “rough sleepers,” the subgroup of unsheltered urban homeless people who avoid emergency… read more here.

Keywords: death; homeless adults; unsheltered homeless; mortality ... See more keywords

Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.

Sign Up to like & get
recommendations!
Published in 2021 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2021.3942

Abstract: Importance In the US, most postmarket medical device safety data are obtained through adverse event reports that are submitted to the US Food and Drug Administration (FDA)'s Manufacturer and User Facility Device Experience (MAUDE) database.… read more here.

Keywords: event reports; death; adverse event; medical device ... See more keywords